Vector Purification Research Report 2025-2035: 100+ Products, 1,000+ Clinical Trials and Rising Demand for Adenoviral and Lentiviral Therapies Drive Global Growth [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class B (BIO.B)
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
Opportunities lie in developing scalable purification techniques, particularly affinity chromatography. The market is driven by North American companies, with substantial demand in oncology and neurological disorders. Viral Vector Purification Products Viral Vector Purification Products Clinical Trial Analysis Clinical Trial Analysis Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Vector Purification Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Viral Vector, Type of Purification Technique, Type of Therapy, Therapeutic Area, Scale of Operation, and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering. The global vector purification market valued at USD 155 million in the current year is anticipated to grow at a lucrative CAGR of 21% during 2025-2035 Viral vectors are the biological tools that are used to transport genetic material to the target cell. Despite being a complex and resource-intensive process, deve
Show less
Read more
Impact Snapshot
Event Time:
BIO.B
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO.B alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO.B alerts
High impacting Bio-Rad Laboratories, Inc. Class B news events
Weekly update
A roundup of the hottest topics
BIO.B
News
- A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO) [Yahoo! Finance]Yahoo! Finance
- Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday [Yahoo! Finance]Yahoo! Finance
- Investors in Bio-Rad Laboratories (NYSE:BIO) have unfortunately lost 47% over the last five years [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away [Yahoo! Finance]Yahoo! Finance
- Non-Viral Transfection Reagents Market Industry Trends and Forecasts to 2035: Patents, Partnerships, and Big Pharma Initiatives Accelerate Non-Viral Transfection Reagents Market Growth [Yahoo! Finance]Yahoo! Finance